Last Posted: Dec 21, 2020
- Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.
Mozersky Jessica et al. Journal of Alzheimer's disease : JAD 2020 Dec - Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
Daunt P et al. The journal of prevention of Alzheimer's disease 2021 8(1) 78-83 - Current Clinical Applications of in vivo Gene Therapy with AAVs.
Mendell Jerry R et al. Molecular therapy : the journal of the American Society of Gene Therapy 2020 Dec - Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's disease.
Lawingco Ted et al. Neurobiology of aging 2020 Nov - Polygenic Risk Scores for Genetic Counseling in Psychiatry: Lessons Learned from other Fields of Medicine.
Eeltink E et al. Neuroscience and biobehavioral reviews 2020 Dec - Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
NC Cullen et al Nature Aging, November 30, 2020 - Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol.
Mega Anna et al. Alzheimer's research & therapy 2020 Nov 12(1) 152 - Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer's Disease: A Systematic Review.
de la Fuente Garcia Sofia et al. Journal of Alzheimer's disease : JAD 2020 Nov - Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
Jia Longfei et al. Brain : a journal of neurology 2020 Nov - The Use of Motor Cognitive Dual-Task Quantitative Assessment on Subjects with Mild Cognitive Impairment: A systematic Review.
Mancioppi Gianmaria et al. Mechanisms of ageing and development 2020 Nov 111393
Search Result Summary
- CDC Information (14)
- NIH Information (7)
- CDC Publications (1)
- Human Genome Epidemiologic Studies (4177)
- GWAS Studies (129)
- Human Genomics Translation/Implementation Studies (139)
- Genomic Tests Evidence Synthesis (13)
- Genomic Tests Guidelines (3)
- Tier-Classified Guidelines (0)
- Non-Genomics Precision Health (55)
- Pathogen Advanced Molecular Detection (4)
- State Public Health Genomics Programs (1)
- Ethical/Legal and Social Issues (ELSI) (3)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 28, 2020
- Content source: